• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型糖尿病性类脂质渐进性坏死性溃疡:病例研究

Atypical Ulcerative Necrobiosis Lipoidica Diabeticorum: A Case Study.

作者信息

Blevins Maryellen

机构信息

Samaritan Medical Center, Watertown, NY, USA.

出版信息

Int J Low Extrem Wounds. 2023 Mar;22(1):185-189. doi: 10.1177/1534734621999269. Epub 2021 Mar 20.

DOI:10.1177/1534734621999269
PMID:33745343
Abstract

Necrobiosis lipoidica is a granulomatous skin condition commonly associated with diabetes. When associated with diabetes mellitus, the name expands to necrobiosis lipoidica diabeticorum (NLD). In these patients, this rare condition has an incidence rate of 0.3% to 1.6%. The cause of NLD remains unknown even though many speculations exist in the medical literature. The treatment of this condition has most researchers agreeing on the use of topical steroids for the anti-inflammatory effect on NLD; however, the role of glucose control in the treatment of this disorder has been debatable. The following case presents a patient who, despite better glucose control, did not improve until the introduction of doxycycline.

摘要

类脂质渐进性坏死是一种通常与糖尿病相关的肉芽肿性皮肤病。当与糖尿病相关时,其名称扩展为糖尿病性类脂质渐进性坏死(NLD)。在这些患者中,这种罕见疾病的发病率为0.3%至1.6%。尽管医学文献中有许多推测,但NLD的病因仍然不明。对于这种疾病的治疗,大多数研究人员都同意使用外用类固醇来对NLD产生抗炎作用;然而,血糖控制在这种疾病治疗中的作用一直存在争议。以下病例介绍了一位患者,尽管血糖控制有所改善,但在引入强力霉素之前病情并未好转。

相似文献

1
Atypical Ulcerative Necrobiosis Lipoidica Diabeticorum: A Case Study.非典型糖尿病性类脂质渐进性坏死性溃疡:病例研究
Int J Low Extrem Wounds. 2023 Mar;22(1):185-189. doi: 10.1177/1534734621999269. Epub 2021 Mar 20.
2
Necrobiosis lipoidica and diabetic control revisited.脂性渐进性坏死与糖尿病控制再探讨。
Med Hypotheses. 1996 Apr;46(4):348-50. doi: 10.1016/s0306-9877(96)90184-x.
3
Anti-TNFα treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature.抗TNFα治疗顽固性糖尿病性类脂质渐进性坏死:一例报告及文献复习
Metabolism. 2016 Apr;65(4):569-73. doi: 10.1016/j.metabol.2015.12.014. Epub 2016 Jan 7.
4
[Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].[用阿达木单抗成功治疗一名非糖尿病性溃疡性类脂质渐进性坏死患者]
Hautarzt. 2013 Jul;64(7):509-11. doi: 10.1007/s00105-013-2535-z.
5
Necrobiosis lipoidica diabeticorum: necrobiosis lipoidica diabeticorum in a Nigerian from the north. A case report.糖尿病性类脂质渐进性坏死:一名来自尼日利亚北部的患者的糖尿病性类脂质渐进性坏死。病例报告。
Niger J Med. 2013 Oct-Dec;22(4):357-61.
6
Necrobiosis lipoidica diabeticorum: a clinicopathologic study.糖尿病性类脂质渐进性坏死:一项临床病理研究。
J Am Acad Dermatol. 1988 Mar;18(3):530-7. doi: 10.1016/s0190-9622(88)70076-6.
7
Resolution of long-standing necrobiosis lipoidica diabeticorum (NLD) lesion after restoration of euglycemia following successful pancreas after kidney (PAK) transplantation: a case report.肾胰联合移植(PAK)成功后恢复正常血糖水平后,长期存在的糖尿病性脂性渐进性坏死(NLD)病变得以消退:一例报告
Transplant Proc. 2011 Nov;43(9):3296-8. doi: 10.1016/j.transproceed.2011.10.005.
8
Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case.英夫利昔单抗治疗难治性糖尿病性类脂质渐进性坏死性溃疡:病例报告
Arch Dermatol. 2009 Apr;145(4):437-9. doi: 10.1001/archdermatol.2009.6.
9
[Successful therapy of ulcerated necrobiosis lipoidica non diabeticorum with cyclosporine A].[环孢素A成功治疗非糖尿病性溃疡性类脂质渐进性坏死]
Hautarzt. 2007 Aug;58(8):684-8. doi: 10.1007/s00105-006-1282-9.
10
Necrobiosis lipoidica diabeticorum treated with chloroquine.用氯喹治疗的糖尿病性类脂质渐进性坏死。
J Am Acad Dermatol. 2002 Feb;46(2 Suppl Case Reports):S34-6. doi: 10.1067/mjd.2002.104969.

引用本文的文献

1
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience.探讨光动力学疗法治疗类脂质渐进性坏死:多中心真实世界经验。
Int J Mol Sci. 2024 Mar 23;25(7):3608. doi: 10.3390/ijms25073608.
2
Tetracyclines-An Important Therapeutic Tool for Dermatologists.四环素类——皮肤科医生的重要治疗工具。
Int J Environ Res Public Health. 2022 Jun 13;19(12):7246. doi: 10.3390/ijerph19127246.